首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Hepatology communications

缩写:

ISSN:N/A

e-ISSN:2471-254X

IF/分区:4.6/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1933
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Donna M Evon,Chuning Liu,Cathryn Rollason et al. Donna M Evon et al.
Background: Group-based, telehealth behavioral interventions may be efficient, effective, and acceptable treatment modalities for patients with chronic liver diseases; however, pilot feasibility and patient satisfaction d...
Ananya Venkatesh,Nhat Thai,Patricia Ugalde-Nicalo et al. Ananya Venkatesh et al.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common pediatric liver disease, yet known biological risk factors do not fully explain its development. This study evaluated the ass...
Aalam Sohal,Laura A Wilson,David E Kleiner et al. Aalam Sohal et al.
Background: We previously showed that the pattern of liver biopsy iron staining is associated with metabolic dysfunction-associated steatohepatitis (MASH) severity and fibrosis. The goal of the current study was to furthe...
Andrea Ricci,Elena Corradini,Elena Buzzetti et al. Andrea Ricci et al.
In humans, an enzyme dysfunction in heme biosynthesis results in a heterogenous group of diseases collectively known as porphyrias. From a clinical standpoint, porphyrias can be classified as erythropoietic (congenital erythropoietic porphy...
Heike Bantel,Gideon M Hirschfield,David E Jones et al. Heike Bantel et al.
Background: There is variability in primary biliary cholangitis (PBC) care delivery in practice, which can negatively impact disease management and patients' quality of life. Patient-provider consultations are key to ensu...
Sara Schwenk,David E Kaplan Sara Schwenk
Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer and a leading cause of cancer-related deaths globally. Chronic liver disease (CLD), primarily due to viral hepatitis, alcohol use, and metabolic dysfunction-asso...
Miao Ding,Guoqing Zhu,Tianshu Chen et al. Miao Ding et al.
Background: Hepatoblastoma is the most prevalent liver cancer in children. Immunotherapy targeting immune checkpoint molecules has become pivotal in various cancer treatments. However, the clinical significance of immune ...
Chiara Becchetti,Elton Dajti,Grace L Su et al. Chiara Becchetti et al.
Background: Sarcopenia and frailty have a negative prognostic impact in patients with decompensated cirrhosis; however, the impact of these conditions on the prognosis of compensated cirrhosis is unknown. We performed a s...
Tin Lok Wong,Yanshu Kong,Stephanie Ma Tin Lok Wong
Liver cancer, with hepatocellular carcinoma (HCC) as its predominant form, remains among the deadliest malignancies worldwide. Despite the expanding array of treatment options, current therapies benefit only a limited subset of patients. Me...
Laila M Elias,Jordy E Agins,David S Goldberg et al. Laila M Elias et al.
Background: Chronic liver disease (CLD) poses a significant healthcare burden, with diet playing a crucial role in its management. Food insecurity, defined as limited or uncertain access to adequate food, may worsen liver...